Updated results: Phase I trial of autologous CD19-targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy Meeting Abstract
| Authors: | Geyer, M. B.; Park, J. H.; Riviere, I.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R. J. |
| Abstract Title: | Updated results: Phase I trial of autologous CD19-targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 401s |
| Language: | English |
| ACCESSION: | WOS:000404711505039 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.7526 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7526 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
